Fewer than 10% of patients in England who are eligible for what has been dubbed the “King Kong of weight loss drugs” will initially be able to access it on the health service, after officials revealed they are prioritising people with the highest needs.
The “difficult decision” was made “in order to protect other vital NHS services”, the National Institute for Health and Care Excellence (Nice) said.
